EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 3.0

Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1 [Letter]

Vidak Raičević

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s491658 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Vidak Raičević. Beteiligte Einrichtung: Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia. Hauptthemen laut MEDLINE: Signal Transduction, LIM Domain Proteins, Mouth Neoplasms, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Suppresses the Progression of Human Oral

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionLIM Domain ProteinsMouth NeoplasmsAdaptor Proteins, Signal TransducingHumansCytoskeletal ProteinsAntineoplastic AgentsJanus KinasesCell ProliferationSTAT Transcription FactorsDisease ProgressionDrug Screening Assays, Antitumor

Substanzen

LIM Domain ProteinsAdaptor Proteins, Signal TransducingCytoskeletal ProteinsAntineoplastic AgentsJanus KinasesSTAT Transcription Factors

Autor:innen und Institutionen

  • Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Zitieren

APA

Raičević, V. (2024). Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1 [Letter]. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s491658

Vancouver

Raičević V. Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1 [Letter]. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s491658

BibTeX
@article{Raievi2024,
  author = {Raičević, Vidak},
  title = {Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1 [Letter]},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s491658}
}
Kostenlos starten →